Trade Therapy

Page 40

24

Trade Therapy: Deepening Cooperation to Strengthen Pandemic Defenses

Box 1.1

Access to health care: The role of (trade in) health insurance services

Appropriately regulated (such as to ensure equity, protect consumers, and avoid cost escalation) and adapted to local needs and preferences, private health insurance—and potentially trade in health insurance services in that context—can play a positive role in improving access to health care in low- and middle-income countries. Benefits of private health insurance Two main benefits explain the potentially positive role of private health insurance: First, private health insurance may help households avoid large out-of-pocket spending on health services (the most common form of health financing in low- and middle-income countries). Second, when available to those who can afford it, private coverage allows the publicly financed health care system to focus on the most vulnerable groups (Sekhri and Savedoff 2005). Although private health insurance is no panacea for universal health coverage (UHC), it may help to expand access to health care in various ways. Available research on UHC shows that, although the overall effect of private health insurance on UHC is ambiguous, compulsory private health insurance schemes are positively and significantly associated with specific health service coverage indicators (Wagstaff and Neelsen 2020). Still, no two markets are the same, and depending on how national health care systems are organized, private health insurance may play a positive role. Private health insurance may be compulsory or voluntary. In the latter case, private insurance may play a supplementary role (allowing users to overcome the flaws of publicly financed systems, such as long waiting times); a complementary role (allowing users to fill the gaps in noncomprehensive publicly financed protection schemes); or a substitutive role (for users excluded from public schemes on grounds of age or income or who are allowed to choose between private and public coverage) (Thomson, Sagan, and Mossialos 2020). Private health insurance plays an important role in health care financing in both high-income economies and low- and middle-income economies, and its role is not restricted to any particular region or level of development. Even in countries where UHC has been achieved, private health insurance (either voluntary or compulsory) continues to be significant. Figure B1.1.1 shows selected countries where private health insurance contributes at least 10 percent of current health expenditure. Impact of regulation and policy on health insurance trade Although trade in health insurance (in particular through commercial presence) is feasible in ­practice, restrictive regulation and policy, among other factors, may hinder uptake. As shown in figure B1.1.1, various low- and middle-income economies have a significant proportion of health care financed through insurance spending. Together with inadequate demand due to a population’s risk aversion or misperception and the potentially high administrative costs involved (which may be higher than the risk premium that users are willing to pay), supply restrictions motivated by regulation may explain the small size of health insurance markets in many economies (Pauly et al. 2006). Services trade policy may help widen the health insurance market and thus contribute— among many other factors—to expanding health insurance coverage. Adequately regulated (to ensure equity, protect consumers, and avoid cost escalation), foreign health insurance suppliers (Continued )


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

response for future pandemics

18min
pages 177-187

Notes

11min
pages 165-168

References

12min
pages 169-174

3.2 Low levels of GATS commitments in medical services trade

1min
page 147

commitments than in GATS

15min
pages 148-154

Cooperation beyond trade agreements for global health security

22min
pages 155-164

3.3 Potential commitments to bolster governance of trade policy in global crises

20min
pages 131-139

Trade policy cooperation to contribute to global health security

3min
pages 127-128

3.5 Traceability and illicit trade in medical products in Africa

5min
pages 145-146

B3.4.2 Types of health technology transfer programs reported by WTO developed country members under TRIPS Agreement, art. 66.2, 2018–20

5min
pages 142-144

3.2 Pricing policies for medical goods in the context of international trade

6min
pages 124-126

3.1 RTA cooperation during the COVID-19 pandemic

6min
pages 121-123

References

12min
pages 114-118

Policies affecting medical goods and services trade during the COVID-19 pandemic

2min
page 96

the onset of the COVID-19 pandemic (excluding China), January 2020 to March 2022

5min
pages 108-110

Notes

8min
pages 111-113

2.11 NRA decisions on WHO-EUL COVID-19 vaccines, December 2020 to February 2022

8min
pages 104-107

2.7 Government support measures for the medical goods sector predated the pandemic

6min
pages 93-95

2.4 Trade in medical services faces many trade barriers

5min
pages 88-90

References

8min
pages 71-74

2.2 WTO-notified quantitative restrictions, by type and member income group, 2018–19

3min
pages 80-81

2.3 Progress on implementation commitments under the WTO Trade Facilitation Agreement

10min
pages 82-86

1.22 The vaccine value chains

3min
pages 68-69

2.2 Development of export-oriented medical services in selected countries

2min
page 87

1.17 Exports of PPE soared early in the COVID-19 pandemic

0
page 63

Notes

2min
page 70

1.11 Trade in medical services hit US$78.6 billion in 2019

1min
page 56

1.3 Recent FDI trends in medical goods and services

2min
page 46

Personnel—and the blurred boundaries between trade in medical services and migration of health workers

5min
pages 43-44

1.6 MNCs’ contribution to global value added and exports varies by industry

3min
pages 50-51

Patterns in medical goods and services trade before the pandemic

2min
page 52

B1.1.1 Private health insurance schemes as a share of total health expenditure in selected countries, 2019

3min
pages 41-42

1.1 Access to health care: The role of (trade in) health insurance services

2min
page 40

Drivers of trade in medical goods and services

2min
page 36

of medical goods and services, leading to concentration

8min
pages 32-35

Notes

1min
page 23

1 Trade and trade-related policy actions to improve prevention, preparedness, and

2min
page 20

Deepening cooperation on medical goods and services trade

4min
pages 21-22

Stronger trade systems for better global health security

1min
page 25

References

1min
page 24

Organization of the report

1min
page 26

Reference

0
pages 27-28

The medical goods and services trade: Relevance, characteristics, and welfare implications

1min
page 29
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.